| 注册
首页|期刊导航|中国药业|基于信息生态理论的数字化药物警戒生态体系构建研究

基于信息生态理论的数字化药物警戒生态体系构建研究

茅鸯对 王广平

中国药业2026,Vol.35Issue(2):1-6,6.
中国药业2026,Vol.35Issue(2):1-6,6.DOI:10.3969/j.issn.1006-4931.2026.02.001

基于信息生态理论的数字化药物警戒生态体系构建研究

Study on the Construction of A Digital Pharmacovigilance Ecosystem Based on Information Ecology Theory

茅鸯对 1王广平2

作者信息

  • 1. 浙江药科职业大学,浙江 宁波 315100
  • 2. 上海市药品和医疗器械不良反应监测中心,上海 200040
  • 折叠

摘要

Abstract

Objective To construct a digital pharmacovigilance ecosystem based on information ecology theory.Methods Relevant literatures on digital pharmacovigilance were retrieved from CNKI,PubMed,and EBSCO databases,The application paths for artificial intelligence,large language models,digital twins,big data,and cloud computing in pharmacovigilance were proposed,and summarized the advanced experiences of digital technology application in pharmacovigilance in foreign countries.Results and Conclusion Various digital technologies such as artificial intelligence and digital twins are developing rapidly and have become a key driving force for the reform of the pharmacovigilance system.By empowering all links of pharmacovigilance,digital technologies have significantly improved the efficiency and accuracy of drug safety monitoring,providing strong support for the efficient implementation of pharmacovigilance.From the perspective of information ecology theory,a digital pharmacovigilance ecosystem with four core elements:pharmacovigilance information platform,digital technology,responsible subject,and social environment are constructed.The information chain is used to connect the industrial chain,risk chain,and responsibility chain,which can enhance the predictability,targeting,and timeliness of pharmacovigilance,improve the efficiency and quality of pharmacovigilance management,and ensure the safety of patients'medication use.

关键词

信息生态理论/药物警戒/药品不良反应/数字化/生态体系

Key words

information ecology theory/pharmacovigilance/adverse drug reaction/digitalization/ecosystem

分类

医药卫生

引用本文复制引用

茅鸯对,王广平..基于信息生态理论的数字化药物警戒生态体系构建研究[J].中国药业,2026,35(2):1-6,6.

基金项目

浙江省哲学社会科学规划课题[23NDJC446YBM] ()

浙江省社会科学界联合会研究课题[2024B077] ()

浙江省药品监督管理局科技计划项目[2025034] ()

国家药品监督管理局药品评价中心专项研究项目[CDR2024R01004]. ()

中国药业

1006-4931

访问量0
|
下载量0
段落导航相关论文